Clinical trialNCT07225387RecruitingPhase 4Interventional

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

SponsorNephroNet, Inc.Enrollment30Lupus Nephritis

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

James Tumlin, MD
NephroNet, Inc.
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Aara Clinical Research
Glendale, Arizona, United States
Eric Peters, MD
Recruiting
Piedmont Physicians Rheumatology
Atlanta, Georgia, United States
Wambui Machua, MD
Recruiting
Georgia Nephrology Research Institute
Lawrenceville, Georgia, United States
James A Tumlin, MD
Recruiting
Parris & Associates
Lawrenceville, Georgia, United States
Glen Parris, MD
Recruiting
Nephrology Clinical Trials Unit the Ohio State University Wexner Medical Center
Columbus, Ohio, United States
Isabelle Ayoub, MD
Recruiting
Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma, United States
Christina Arriens, MD
Recruiting
Aara Clinical Research
Fort Worth, Texas, United States
Shariq Chudhri, DO
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Oct 2024
Primary completion: 31 Jan 2027
Completion: 31 Jan 2027
Last update posted: 6 Nov 2025
Registered enrollment: 30
Registry id: NCT07225387

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.